Globus Medical Inc. (GMED)
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.
All You Need to Know About Globus Medical (GMED) Rating Upgrade to Strong Buy
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why Is Globus Medical (GMED) Down 9.2% Since Last Earnings Report?
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
Bridgefront Capital LLC Invests $667,000 in Globus Medical, Inc. $GMED
Bridgefront Capital LLC acquired a new stake in Globus Medical, Inc. (NYSE: GMED) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 11,642 shares of the medical device company's stock, valued at approximately $667,000. Several other institutional investors and hedge funds also
Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now
Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.
Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock?
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's What Key Metrics Tell Us About Globus Medical (GMED) Q4 Earnings
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
